MEDIA KIT 2018 - New YORK CITY October 25, 2018 - Galien Foundation
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
MEDIA KIT 2018 New YORK CITY October 25, 2018
/4 PRIX GALIEN USA FOUNDING COMMITTEE
/5 2018 AWARDS COMMITTEE
/ 6-7 GALIEN FORUM
Overview & Background
“They participated in the Forum”
/ 8-9 TESTIMONIALS FROM AROUND THE GLOBE
/ 10 HALL OF FAME - HISTORY OF THE PRIZE AND MEDAL
/ 11 PRIX GALIEN USA
/ 12 THE PRO BONO HUMANUM AWARD
/ 13 WHO WAS GALEN
/ 14 PRIX GALIEN MEDSTART UP
/ 15 PRIX GALIEN USA WINNERS
Pre-event & On-site
Resources for Journalists
For more information and
Galien Foundation events are conducted fully on the record, and we welcome
register for a press pass
and invite members of the media to participate as engaged stakeholders via
onsite discussion, as well as via social media, and to report on proceedings
please contact:
and outcomes.
Finn Partners
Holmes Report & PR News
We certainly appreciate coverage of our events, but our priority is to help you
Midsize Agency of the Year
explore and uncover today’s key issues and connect with the people and diverse
organizations we bring together that make the world a healthier place. Contact:
Giana Gregga
To help facilitate your engagement with our speakers and stakeholders, T +1 312 329 3910
we are delighted to work with you in the lead-up to our 2018 Forum and M +1 708 703 2210
Ceremony on: giana.gregga@finnpartners.com
Arranging interviews with key speakers Helpful links
and stakeholders www.galienfoundation.org
Prix Galien USA
Reserving private spaces for on-site interviews
Forum (latest programs, participants,
Sharing our latest programs and speaker lists registration, and reports)
Pro Bono Humanum Award
Providing hi-resolutions imagery (including photos Med StartUp Award
of people, spaces, logos, etc.)
Prix Galien Around the Globe
Prix Galien Hall of Fame
2
innovation to improve
the human condition
Mission
Sue Desmond-Hellmann,
Ethiopia Clinic site visit
The Prix Galien Award recognizes
outstanding achievements in improving
the global human condition through the
and politics. The outcome we seek is guided by the
development of innovative drugs and synthesis principle that underpins the conduct of
other treatments. science itself: successful innovation where financing,
physical assets, knowledge and skills are combined
from many sources to move new ideas quickly “from
The Prix Galien was created in 1970 in the bench to the bedside,” on behalf of patients
everywhere.
honor of Galen, the father of medical
science and modern pharmacology.
A truly global program present in 14 countries*
Our program includes a review of contributions from
Worldwide the Prix Galien is regarded a new generation of innovators representing diverse
as the equivalent of the Nobel Prize in sectors in health. Our theme: better cross-cultural
contacts, harmonized regulation, internal business
biopharmaceutical research. process improvements, new information technologies
and effective public-private partnerships can remove
barriers to the commercialization of good medicines and
The Prix Galien is more than an award: it is a expand access to these benefits to all who need them.
movement with a mandate to foster, recognize and
reward excellence in scientific innovation to improve
the state of human health. Building on an unrivaled 2018
network of Top biomedical scientists including Nobel Through our partnership with the Élie Wiesel Foundation
Laureates in medicine, the Prix Galien manages an for Humanity and our first initiative in Africa, 2018 will
independent, cross-functional and geographically represent a new and exciting stage in the evolution of
diverse program of events and sponsorships to the Prix Galien as the pre-eminent “force populaire”
brand “the best of the best” in new medicines and behind the global scientific enterprise. With the support
diagnostics. of our sponsoring organizations, our efforts will extend
to all who see medical innovation not only as an
Our scope is global, and our commitment to industrial policy asset but as a source of social progress
progress in medicine is both measurable and concrete. – where private enterprise and public engagement
Our members express this through the establishment combine to deliver a greater public good.
of productive relationships to build lasting bridges
between the commercial research enterprise and local We invite all communities with a commitment to the
communities engaged in public policy, science, finance, conduct and promotion of life sciences innovation to
academic research and the media. contribute to this important work.
In addition to recognizing advances in promising
therapies, the Prix Galien’s annual Pro Bono Humanum * Belgium, Canada, China, France, Germany, Greece, Italy,
Award for humanitarian achievements brings a unique Netherlands, Poland, Russia, Spain, Switzerland, United
focus to the intersection between science, business Kingdom and the United States.
3
Elie WIESEL In Memoriam
Honorary Founding President
The Galien Foundation
Peace Nobel Laureate
Boston University
Committee 2007-2011
Michael S. BROWN, MD Barry S. COLLER, MD Walter GILBERT, PhD Joseph GOLDSTEIN, MD
Nobel Laureate Vice President for Nobel Laureate Nobel Laureate
Professor of Molecular Medical Affairs Professor Emeritus Professor of Molecular
Genetics and Internal Medicine and Physician-in-Chief, Harvard University Genetics and Internal Medicine
UT Southwestern Rockefeller University UT, Southwestern
Medical Center at Dallas Medical Center at Dallas
Paul GREENGARD, PhD Eric R. KANDEL, MD Joshua LEDERBERG, M.D. Ph.D. Richard A. LERNER, M.D.
Nobel Laureate Nobel Laureate Nobel Laureate Professor of Immunochemistry,
Professor of Molecular Professor of physiology Professor Emeritus, Chair in Chemistry
and Cellular Neuroscience and Cellular Biophysics Laboratory of Molecular Genetics Scripps Research Institute
Rockfeller University Columbia University and Informatics,
Rockefeller University
Paul A. MARKS, MD Bengt SAMUELSSON, MD, PhD Jan T. VILCEK, M.D. Gerald WEISSMANN, M.D.
Laboratory Head of Cell Biology Nobel Laureate Professor of Microbiology Professor of Rheumatology
Memorial Sloan Kettering Professor Karolinska Institutet; New York University School and Director of Biotechnology
Cancer Center Former President Karolinska of Medicine Study Center
Institutet; Former Chairman New York University School
Nobel Foundation of Medicine
4
AWARDS
COMMITTEE
2018
Susan DESMOND-HELLMANN,
MD, MPh
Richard AXEL, MD Michael S. BROWN, MD Laurie GLIMCHER, MD
Committee Chair Nobel Laureate Nobel Laureate President and CEO
Chief Executive Officer Co-director Dana Farber Cancer Institute;
Professor of Molecular Genetics
The Kavli Institute for Brain Professor of Medicine
Bill & Melinda Gates Foundation and Internal Medicine
Science. Columbia University Harvard Medical School
UT Southwestern Medical
Medical Centre
Center at Dallas
Joseph GOLDSTEIN, MD Robert S. LANGER Cato T. LAURENCIN, MD, PhD Paul A. MARKS, MD
Nobel Laureate David H. Koch Institute Professor University Professor Laboratory Head of Cell Biology
Professor of Molecular Genetics MIT University of Connecticut Memorial Sloan Kettering
and Internal Medicine Cancer Center
UT, Southwestern Medical
Center at Dallas
Michael ROSENBLATT, MD Bengt SAMUELSSON, MD, PhD Marc TESSIER-LAVIGNE, PhD P. Roy VAGELOS, MD
Chief Medical Officer Nobel Laureate President Prix Galien USA
Flagship Pioneering at Dallas Professor Stanford University Committee Chairman 2012-2017
Karolinska Institutet;
Retired Chairman and CEO
Former President Merck & Co., Inc.;
Karolinska Institutet;
Chairman of the Board
Former Chairman Regeneron Pharmaceuticals, Inc.
Nobel Foundation
5
Galien FORUM
october 25, 2018 - 7:30AM
ALEXANDRIA CENTER FOR LIFE SCIENCE
NEW YORK CITY
The Galien Forum, held every autumn at New York’s Alexandria Center for
Life Sciences since 2010, offers a full day of dynamic presentations and
spirited discussions with top scientists and industry researchers who
offer perspectives on the most significant challenges in the global burden
of disease and highlight the latest research and clinical pathways toward
diagnosis, treatment, and cure.
Topics debated at previous forums include:
Our 700 attendees represent the top executive and thought
> Cancer Immunotherapeutics
leadership from academic research, industry, government, the
regulatory community, patient organizations, international > The Brain Initiative
organizations, and the media. Time and again, Forum participants > Personalized Medicine’s Impact on Drug R&D and Patient Care
praise the caliber of the speakers and their fellow attendees, > Improving efficiency in Drug Development
the quality of the panel discussions and presentations, and
> What is “Value” and How Can it be Measured and
the recognition of industry’s critical role in creating life-saving
innovations. Demonstrated in Therapeutic Innovations?
> U.S. Health Reform
These events represent peer-to-peer exchange with a public > A New Agenda for Global Health
purpose, and they feature unique opportunities to connect with
> The Future of Digital Health and its Impact on Healthcare
a diverse range of people, organizations, and interests, from
professional and scientific groups, academia and governments to > New Mechanisms for Industry-Academia Collaboration
patient associations, non-profit organizations and the media. > The Future of Targeted Drug Delivery
> Microbiota in Human Disease
Visit the forum webcast to read our
> Autism - The Next Decade
2017 Forum Report on people and
substance and to see videos and > Untangling the Web of Neurodegeneration
photos from the event > Precision Medicine: Delivering on the Promise
> Molecular Scissors: What Can We Expect from Gene Editing?
6
AMONG
THE PREVIOUS
GALIEN
FORUM
SPEAKERS
Richard Axel, MD Cori Bargmann PhD Michael Bloomberg Michael S. Brown Dr Samantha Budd Rory Collins Mikael Dolsten, MD, PhD
Nobel Laureate Rockefeller University Former Mayor Nobel Laureate Vice President Co-director President, Worldwide
Co-director City of New York Professor of Molecular Neuroscience iMed, University of Oxford Research and Development
Kavli Institute Genetics and Internal AstraZeneca R&D Clinical Trials Unit Pfizer
for Brain Science, Medicine
Columbia University UT Southwestern Medical
Medical Centre Center at Dallas
Ezekiel Emanuel, MD, PhD Kenneth C. Frazier Maria C. Freire, PhD Laurie Glimcher, MD Joseph Goldstein Dr Alex Gorsky
Vice Provost for Global Chaiman, CEO and President & Executive CEO and President Nobel Laureate Chaiman and CEO
Initiatives; Chair, President, Director Dana Farber Cancer Professor of Molecular Johnson & Johnson
Dept. of Medical Ethics Merck Foundation for the National Institute; Genetics and Internal
and Health Policy Levy Institutes of Health Professor of Medicine Medicine
University Professor Perelman Harvard Medical School UT, Southwestern Medical
School of Medicine and The Center at Dallas
Wharton School, University of
Pennsylvania
Paul Greengard, PhD William N. Hait, Margaret A. Hamburg, MD Eric R. Kandel, MD Sachin H. Jain, MD, MBA
Nobel Laureate MD, PhD Former Commissioner Nobel Laureate Chief Medical information
Professor of Molecular Global Head, Research U.S. Food and Drug Professor of Physiology and innovation officer
and Cellular Neuroscience and Development Administration and Cellular Biophysics Merck and Co.;
Rockefeller University Janssen Research Columbia University; Lecturer in Healthcare
& Development Director Bio-technology Policy Harvard Medical
Study Center, NYU School School
of Medicine
John Lechleiter Dr Jeffrey Leiden Donald Lloyd-Jones Joel S. Marcus Mark McClellan, MD, PhD Dr Ira Mellman Tara Narula, MD, FACC
Chairman and CEO Chairman, President Chairman, Department Chairman, CEO & Founder Director Vice President Medical Contributor
Eli Lilly & Cie and CEO of Preventive Medicine Alexandria Real Estate Duke-Robert J. Margolis Research Genentech “CBS This Morning”
Veritex Northwestern University Equities / Center for Health Policy;
Alexandria Venture Professor of Business,
Investments; Co-Founder Medicine, and Health Policy
Alexandria Summit Duke University
Guido Rasi Michael Rosenblatt, MD Bengt Samuelsson, George A. Scangos, PhD Dr Morgan Sheng Steven H. Stein, MD
Executive Director Chief Medical Officer MD, PhD Chief Executive Officer Vice President Senior Vice President
European Medicines Flagship Ventures Nobel Laureate Biogen Idec Neuroscience Genentech US Clinical Development
Agency Former President & Medical Affairs
Karolinska Institute Novartis Oncology US
Former Chairman
Nobel Foundation
Marc Tessier-Lavigne PhD P. Roy Vagelos Bert Vogelstein George Yancopoulos, Krishna Yeshwant, MD Elias Zerhouni
President M.D., Retired Chairman Professor MD, PhD General Partner President, Global R&D
Stanford University and CEO, Merck & Co., Inc. Johns Hopkins Medical Chief Scientific Officer Google Ventures Sanofi
Chairman of the Board, School Regeneron Pharmaceuticals
Regeneron Pharmaceuticals President, Regeneron
Laboratories
7
“I applaud Prix Galien for recognizing
the pioneering spirit of America
innovation and research.“
John McCain
American Senator - 2008
“The Prix Galien USA recognizes the
important research necessary to develop
innovative medicines and devices that
have a life-saving impact on individuals
and families across the globe.“
Kathleen Sebelius
American Secretary of Health and
Human Services - 2011
“We recognize the importance of the Prix
Galien in promoting drug research, and
we salute the excellent work of the Jury.“
Philippe Douste-Blazy
French Minister of Foreign Affairs – 2006
“I’d also like to congratulate all the
candidates for the 5th Annual Prix Galien
Awards Competition, which honors those
in the pharmaceutical industry who
“When Olympic rhymes with Galenic: have developed the technical, scientific
there is a gold medal that can be won and clinical research skills necessary
for an extraordinary achievement: to develop innovative medicines and
this is the Galien Award, the Oscar of devices. Your work is invaluable.“
pharmaceutical research.“
Margaret A. Hamburg, M.D.
Walter Sutter Commissioner of Food and Drugs
Swiss State Advisor, Director US Food and Drug Administration - 2011
of the Public Economy - 2004
“The Galien Foundation, created to honor
and catalyze excellence in scientific
innovation, recognizes outstanding
achievement with the prestigious Prix
“Prix Galien recognizes men and women Galien Award.“
from the pharmaceutical and biomedical
industries whose contributions of science Bill De Blasio
have improved and saved countless lives.“ Mayor of the City of New York - 2015
Michael Bloomberg
8 Mayor of the City of New York - 2010
A record of leadership in bringing
the best of biomedical discovery
to the attention of the world…
“
“
“The Prix Galien is the right event, on the “I welcome you to the annual Prix
right issue at the right time. I thank the Galien awards for innovative excellence
Galien Foundation for bringing us together in biomedical products and health
and for recognizing that a healthier world is technologies. The awards are among
a safer world and a more just world.“ the highest honors in science
and commerce..“
BAN Ki-moon
UN Secretary-General - 2010 Jimmy Carter
American President - 2017
“I am particularly grateful
to receive this Award.“
“The Prix Galien is a prestigious award, Bill Clinton
a magnificent occasion to pay American President - 2010
recognition to our researchers and
to encourage our industry.“
Jean Chretien
Canadian Prime Minister - 1994
“It is a pleasure to congratulate all
“I know the importance of the Prix Galien those who promote the Prix Galien and
which rewards every year therapeutic pharmaceutical research: they play a vital
innovations and research works among role in the fight against disease throughout
the most creative.“ the world.“
Emmanuel Macron John Major
French President - 2018 British Prime Minister - 1996
“The Prix Galien since 1970 is dedicated
“The Prix Galien is a welcome to promoting the research
initiative to stimulate creative and development of the medicine
research and promote excellence.“ and medicine industries.“
Barack Obama Macky Sall
American President - 2008 Senegalese President - 2018
9
PRIX GALIEN
Hall of fame Around the globe since 1970
BY NUMBER OF MEDALS
51 Merck 6 Astra-Zeneca, Inserm, Vertex
45 Novartis 5 Gilead Sciences, Lilly
42 Roche 4 Biogen, Institut Pasteur, Takeda
37 Sanofi 3 Actelion, Alexion, Almirall, Teva
35 GlaxoSmithKline 2 AP-HP, Celgene, Chiesi, CTRS, Edwards Life-sciences,
Fresenius Biotech, Genzyme, Institut Merieux, Ipsen,
32 J&J/Janssen Lundbeck, Pierre-Fabre, Procter & Gamble, PTC Thera-
peutics, Shire Pharmaceuticals
28 Pfizer
1 AAZ, AbbVie, Abbott/AbbVie, Albana Pharma, Army
23 Bristol-Myers Squibb Health Department - France, Astellas, Baxter, Biocodex,
Boston Scientific, Centre of Polymer and Carbon Materi-
17 Bayer als of the Polish Academy of Sciences, Chugaî, Engel-
hardt Institute of Molecular Biology, EOS Imaging, Ferrer,
16 Amgen Genethon, Genentech, Generium, Guerbet, Institut Santa
Creu, Intercept Pharmaceuticals, Insightec, Intermunde,
11 Abbott, Servier Ionis Pharmaceuticals, Leo, LFB, Menarini, Norgine
GmbH, Orphan, Otzuka, PharmaPharm, Roche/Genen-
8 Boehringer Ingelheim tech, Swedish Orphan International, T2 Biosystems,
Uriach, Viron Therapeutics,
Updated December 2017
The
Medal
by Albert de JAEGER
The Prix Galien medal was designed by Albert de Jaeger (1908 – 1992), laureate of
the Premier Grand Prix de Rome architectural prize. De Jaeger designed medals for
prominent figures such as Pope Pius XII (at the Villa Medicis, 1937) and Pope Jean-Paul I,
Presidents Dwight D. Eisenhower and John F. Kennedy, distinguished military leaders
including Marshals Leclerc, Koenig, Montgomery, Marshall and Joukov; the Weizmann
Institute, as well as numerous artists, literary figures and prominent personalities such as Sacha
Guitry, Marcel Proust, Henri de Montherlant, Paul Harris, a number of Nobel Prize laureates, the
Empress of Iran SA Farah Diba, Princess Grace of Monaco, and others…
De Jaeger is also the architect of numerous outstanding monuments in France and throughout the world.
10Our annual gala awards dinner is a creative
Galien AWARDS recognition of the productive and positive power
of partnerships that drive progress in medical
CEREMONY 2018 science. It is peer exchange with a public purpose
- with a diverse range of opportunities for contact
with a range of interests, from professional and
october 25, 2018 scientific groups, academia and governments
6:30 PM to patient associations, other non-profit
organizations and the media.
AMERICAN MUSEUM OF NATURAL HISTORY
NEW YORK CITY
WHAT PREVIOUS “Merck’s mission is to “Our 2016 Prix Galien USA
translate science into awards [for Cosentyx and
PRIX GALIEN medically important Gleevec] … represent years
WINNERS HAVE products that positively of hard work by our scientists.
SAID UPON impact humanity, so it is These wins underscore our
natural for us to support the Prix commitment to addressing the
RECEIVING THE Galien, since it supports exactly that.” unmet medical needs of patients through
HONOUR science-based innovation.”
Kenneth C. Frazier
Chaiman, CEO and President Joseph Jimenez
Merck CEO
Novartis
“The Galien Foundation “Our 2016 Prix Galien award “Our goal — to combine the
brings together the top highlights not only the best science with the most
scientists in the world. breakthrough science behind efficient drug development
You have Nobel Laureates Cologuard, but also the plan and deliver
across the spectrum of unrivaled team that worked to transformational medicines to
scientific disciplines meeting and develop and bring to market an innovation patients in need — is completely aligned
talking with members of the pharmaceutical with the potential to make a significant with the Galien Foundation mission to
industry to see what’s going on at the impact in eradicating colorectal cancer. We promote innovations that improve the
cutting edge, because ultimately that’s are humbled and thankful to be counted human condition.”
going to benefit patients.” among the companies honored by the
Galien Foundation.” Mace L. Rothenberg,
William Hait, MD, PhD M.D. Chief Development Officer, Oncology -
Global Head, Research & Development Graham Lidgard, PhD Pfizer Global Product Development
Janssen, Pharmaceutical Companies of Chief Science Officer
Johnson & Johnson Exact Sciences
11The committee follows a century-old example set in Sweden.
The Prix Galien rewards excellence and novelty, and awards special honors to
those who have served humanity at large. Presented at the Ceremony, the Pro
Bono Humanum Award recognizes exemplary and innovative efforts in improving
the human condition. This special award was presented by the late and beloved
Elie Wiesel, in presence of the Prix Galien USA Committee.
2017 countries. This includes the eradication of the Guinea worm
President Jimmy Carter & The Carter Center disease as well as the MECTIZAN initiative to control the
In recognition of his role as the nation’s 39th President in scourge of river blindness in Africa and Latin America, which
expanding access to childhood immunizations and, for the today serves as a precedent for productive public-private
first time, adding social progress and human rights as a partnerships. The Committee points as well to his selection
foundational principle of US foreign policy. The Prix Galien as recipient of the Nobel Peace Prize in 2002,
USA Committee also commends his unmatched record in in which the Swedish Academy noted his decades of effort
public health provision after leaving office, launching the to promote individual freedoms and economic and social
Carter Center in 1982 and subsequently positioning it as a development for all. These are now recognized around the
leading global donor on programs to control and eradicate world as important drivers of individual health status.
six major communicable diseases prevalent in developing
2016 2015 2014 2013 2012
Paula S. Apsell Pr. Mary-Claire King Bernard Kouchner, M.D. Dr. Anthony Fauci Dr. Francis S. Collins.
In recognition of her early and In recognition of your In recognition of his role in for his paramount Dr. Collins, Director of the
continuing leadership in Making the work in transforming the the creation, from amongst contributions to basic and National Institutes of Health
complexities of science, engineering application of human French doctors, this group of clinical research on the (N.I.H)
and medical research accessible to a genetics to medicine through “Doctors Without Borders” pathogenesis and treatment In recognition of his
mass audience. Through innovative identification of who have lent the modern of immunemediated and contribution to the ethical
broadcast and digital programming the first gene, BRCA1, field of humanitarian infectious diseases. implications of scientific
of the highest journalistic responsible for inherited medicine both legitimacy He currently serves as research
standard, her work has educated, susceptibility to breast and worldwide acclaim and Director of the NIAID and
entertained and enlightened cancer. You also for his fieldwork that has chief of the NIAID Laboratory
successive generations of viewers demonstrated that the nurtured and developed, of Immunoregulation in
on the mysteries that underlie our genomes of humans and not only among public Bethesda, Maryland.
understanding of the natural world. chimpanzees are 99% opinion but also within
And by turning great science into identical, and you pioneered various governments, the
a good story - a human story - Ms. the application of genetic notion of the universality
Apsell shows that scientific literacy sequencing in forensics to of humanitarian action and
is society’s essential line of defense identify victims of human the concept of the Non-
against the destructive forces of fear, rights abuse. Governmental Organization.
ignorance and blight.
2011 2010 2009 2008 2007
Pr. Paul Farmer Bill Clinton and Harvard Professor Barry Bloom Sheldon Segal and the Former Merck CEO Roy
in recognition of his Philippe Douste-Blazy, for bringing the fruits of basic Population Council for their Vagelos, for the River
heroic efforts to do in recognition of their biological science to those global efforts in support of Blindness Program and
“whatever it takes” to outstanding achievements who are most needy. Columbia reproductive health and family his historic decision
improve the lives and in providing treatment for University Earth Institute Director planning. to donate the drug
health of patients in underserved populations Jeffrey Sachs for bringing the Mectizan® to more than
destitute communities through the William J. Clinton fruits of scholarly economics 530 million people in 34
around the world Foundation HIV / AIDS to bear our problems that have countries to treat and
through the Partners in Initiative and the multilateral plagued the world for millennia. prevent river blindness:
Health initiative which organization, UNITAID. “as much as necessary for
he co-founded with as long as necessary.”
Tom White.
12An UNRIVALED REPUTATION FOR
INTELLECTUAL RIGOR AND INTEGRITY…
The Prix Galien USA Committee, a group of highly accomplished individuals from the scientific and research communities,
will judge which among the candidates, independent of any category, is the Best Pharmaceutical Agent (i.e. small molecule),
is the Best Biotechnology Product and which is the Best Medical Technology approved by the FDA in the past ten years. As
few as one or as many as three prizes may be awarded in each of these categories, and from time to time the committee
may decide on awards hors prix. The prizes are awarded for products and agents that improve the human condition.
Elie Wiesel, Peace Nobel Laureate;
BAN Ki-moon, General Secretary, United Nations;
Bill Clinton & Philippe Douste-Blazy,
2010 Prix Galien Pro Bono Humanum Award Laureate
Who was Galien?
Born in 131AD, Galen (Galien in French) is inspired the direction of his life. When he world, studying local plants and remedies,
considered the father of modern medicine was 17, Galen worked as a physician to eventually describing 473 original drugs and
and pharmacology.As an anatomist, the gladiatorial school. At the age of 37, many substances of mineral and vegetable
physiologist, clinician and researcher, Marcus Aurelius summoned him to Rome, origin. Importantly, Galen was the first to
his work formed the basis of a school where he grew in reputation and stature codify the art of preparing active drugs
of thought known as “Galenism”, which as a healer, teacher, researcher and writer. using multiple ingredients. Galen’s faculties
dominated medicine until the Renaissance. His ideas on the functioning of the human of observation, logic and deduction made
In fact, Galen’s works were used as primary body were so well received that he became him the true successor of Hippocrates,
medical reference for nearly two centuries. the personal doctor of young Commodus, and his declaration that the primary aim of
the heir to the Emperor. He died in 201AD. medicine was patient care formed the very
Raised in Pergamos, he studied in Smyrna, During his long and eminent career, Galen cornerstone of modern pharmacy.To quote
Corinth, and Alexandria, the three centers completed over five hundred learned works Jean-Pierre Changeux, “Galen first showed
of medical excellence in the ancient world. addressing anatomy, physiology, pathology, that our mind was in the brain, not in our
Legend has it that Galen was visited medical theory and practice, and many hearts.” It can be said that this was the
by Aesclapius in a dream and that this forms of therapy. He traveled throughout the beginning of experimental medicine.
13The mission of The Prix Galien-MedStartUp program is to foster
private-sector collaborations to treat and cure medical conditions
that pose a threat to public health worldwide and promotes
foster innovative research partnerships among major integrated
pharmaceutical companies, biotech firms, and medical device
manufacturers, producers of vaccines, academic research institutes,
and health care organizations, including e-health vendors.
This unique initiative, which takes place in Best Collaboration/Partnership with an
the same venue and at the same time as the Academic institution in a Breakthrough
Galien Forum, was built on several years of Therapy
cooperation between the Galien Foundation and
Business France with three core goals: A focal point of the program is the active Best Innovative Clinical Trial Design to achieve
participation of the most innovative start-up a Faster and Better Therapeutic Outcome
Strengthen commercial partnerships companies who are seeking US partners to
that bridge the traditional silos between share research and support global commercial Best Use of a Patient-Centered Health
government, industry and academia; development of promising lead technologies. Engagement Technology
Defray the growing complexity and cost Each year the Jury nominates candidates Best Collaboration/Partnership in a
burden of medicines R&D; and for four awards in the following categories: Breakthrough Therapy or Diagnosis
geared to Developing Countries.
Promote cross-border trade, jobs, and
economic growth.
THE JURY ! Chairman:
Bernard POUSSOT
Director, Roche Holding,
Former Chairman & CEO, WYETH
! Roch DOLIVEUX ! François MAISONROUGE
Honorary CEO, Senior Managing Director,
UCB Evercore Partners
! Mikael DOLSTEN ! Paul STOFFELS
Global R&D President, Chief Scientific Officer,
Pfizer Johnson and Johnson
! Jean-Pierre GARNIER ! Elias ZERHOUNI
Former CEO, Global R&D President,
GSK Sanofi
! Franz HUMER
JOIN US ON :
Former CEO,
Roche http://medstartup.galienfoundation.org +
14PRIX GALIEN USA WINNERS
And in 2018, the winners are…
2017 2016 2015
Best Pharmaceutical Product: Best Pharmaceutical Agent: Best Pharmaceutical Agent:
Venclexta™, AbbVie & Genentech Ibrance®, Pfizer, Inc. IMBRUVICA®, Janssen Biotech, Inc.
(a Member of the Roche Group) & Pharmacyclics LLC, an AbbVie
Best Biotechnology Product:
Company
Cosentyx®, Novartis Pharma.
Best Biotechnology Product:
SPINRAZA®, Biogen & Ionis Best Medical Technology: Discovery of the Decade winners: Best Biotechnology Product:
Pharmaceuticals Cologuard®, Exact Sciences Best Pharmaceutical Agent: OPDIVO®, Bristol-Myers Squibb
Gleevec®, Novartis Pharma. KEYTRUDA®, Merck & Co., Inc.
Best Medical Technology:
Exablate Neuro, INSIGHTEC Best Biotechnology Product: Best Medical Technology:
Yervoy®, Bristol-Myers Squibb T2Candida Panel, T2 Biosystems,
Pro Bono Humanum Award: Best Medical Technology: Inc.
Former President Jimmy Carter Sapien 3TM, Edwards Lifesciences
Corpo. Pro Bono Humanum Award:
Pr. Mary-Claire King
Pro Bono Humanum Award:
Paula S. Apsell
2014 2013 2012 2011
Best Pharmaceutical Agent: Best Pharmaceutical Agents: Best Pharmaceutical Agents: Best Pharmaceutical Agent:
Sovaldi® - Gilead Sciences Zelboraf® - Genentech Victrelis® - Merck; Incivek® - Vertex Prevnar13® - Pfizer
Best Biotechnology Product: Best Biotechnology Product: Best Biotechnology Product: Best Biotechnology Product:
HEMACORD® - The New York Zostavax® - Merck Yervoy® - Bristol-Myers Squibb Stelara® - Janssen
Blood Center’s Howard Prolia and XGEVA® - Amgen
P. Milstein Cord Blood Center Best Medical Technology product: Best Medical Technology product:
S-ICD® System - Boston Scientific Sapien® - Edwards Lifesciences’
Pro Bono Humanum Award:
Best Medical Technology: Melody® - Medtronic
Paul Farmer
Trevo ProVue® - Stryker Pro Bono Humanum Award:
Dr. Anthony S. Fauci Pro Bono Humanum Award:
Pro Bono Humanum Award: Dr. Francis S. Collins
Dr. Bernard Kouchner
2010 2009 2008 2007
Best Pharmaceutical Agent: Best Pharmaceutical Agent: Best Pharmaceutical Agent: Best Pharmaceutical Agent:
Coartem® - Novartis Gleevec® - Novartis Isentress® - Merck; Januvia® - Merck;
Selzentry® - Pfizer Chantix® - Pfizer
Best Biotechnology Product: Best Biotechnology Product:
RotaTeq® - Merck & Co. Best Biotechnology Product:
Nplate® - Amgen; Soliris® - Alexion; Best Biotechnology Product:
Best Medical Technology: Promacta® - GSK Infuse® - Wyeth Humira® - Abbott;
xTAG® - Luminex Corporation Gardasil® - Merck
Best Medical Technology: Special therapeutic development:
Pro Bono Humanum Award: Cellsearch® - Veridex (J&J) Revlimid® - Celgene Pro Bono Humanum Award:
Bill Clinton and Dr. Roy Vagelos
Philippe Douste-Blazy Pro Bono Humanum Award:
Pro Bono Humanum Award:
Sheldon Segal
Jeffrey Sachs and Barry Bloom
15OCTOBER 25, 2018
AMERICAN MUSEUM OF NATURAL HISTORY
and the winner is…
Actors win Oscars
...
Innovators
win Prix Galien USA
2017 Exablate Neuro® 2017
Spinraza® / Venclexta TM
2016 Cologuard® / Cosentyx® 2016
Ibrance®
2015 Imbruvica®/ Keytruda®/ 2015
Opdivo® / T2Candida Panel
2014 Hemacord / Trevo®ProVue
TM TM
2014
Sovaldi ®
S-ICD® System
2013 Zelboraf® / Zostavax® 2013
2012 Incivek® / Melody® / Sapien®
2012
Victrelis® / Yervoy®
2011 Prevnar13® / Prolia and XGEVA® / Stelara® 2011
2010 Coartem® / Rotateq® / xTAG® 2010
2009 ® ® ®
Cellsearch / Gleevec / Nplate / Promacta ® 2009
2008 ® ® ® ®
Infuse / Isentress / Revlimid / Selzentry / Soliris ® 2008
2007 Chantix® / Gardasil® / Humira® / Januvia® 2007
The Galien Foundation
99 John Street, Suite 2502
The Galien Foundation New York, NY 10038
99 John Street , Suite 2502. Tel: 212-685-1592
New York, New York 10038
www.galienfoundation.org
212-685-1592You can also read
